A New Era for Basal Insulin Managing Type 2 diabetes just became significantly more convenient. The FDA has officially approved Onswik (insulin efsitora alfa), a revolutionary basal insulin designed to be administered just once weekly for adults living with Type 2 diabetes. This marks a major shift from the traditional daily insulin injections that millions…